FDA Inspection
BOEHRINGER INGELHEIM PROMECO S.A. de C.V.BOEHRINGER INGELHEIM PROMECO S.A. de C.V. – FDA Inspection, May 20, 2022
Record Details
This FDA Inspection record concerns BOEHRINGER INGELHEIM PROMECO S.A. de C.V., with an inspection on May 20, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 20, 2022
- Product Type
- Drugs
View Company Profile
ID · e3f1b968-b78b-43ea-9213-e9465ed15259
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1170081
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.48(a)Potable water standards not met
- 21 CFR 211.22(c)Approve or reject procedures or specs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BOEHRINGER INGELHEIM PROMECO S.A. de C.V.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2024 | Not classified | Office of Inspections and Investigations | |
| December 6, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 8, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BOEHRINGER INGELHEIM PROMECO S.A. de C.V.
- FDA Inspection 1303242 - 2024-02-09
- FDA Inspection 1115474 - 2019-12-06
- FDA Inspection 1040046 - 2017-12-08
- FDA Inspection 955438 - 2015-11-20
- FDA Inspection 841397 - 2013-06-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.